NxStage Medical, Inc. · Lawrence, MA United States (NASDAQ: NXTM)
Key NxStage Medical, Inc. Financials
| Company Type | Public -(NASDAQ: NXTM) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2003 Sales (mil.) | $0.3 |
| 2010 Employees | 1,600 |
NxStage Medical, Inc. Income Statement
| Dec 03 | Dec 02 | Dec 01 | |
| Revenue | 0.3 | 0.0 | 0.0 |
| Cost of Goods Sold | 0.9 | 0.4 | 0.0 |
| Gross Profit | (0.7) | (0.4) | 0.0 |
| Gross Profit Margin | -228.9% | -1246.7% | -- |
| SG&A Expense | 5.1 | -- | 4.1 |
| Depreciation & Amortization | 0.4 | -- | -- |
| Operating Income | (10.3) | (11.1) | (11.8) |
| Operating Margin | -3588.9% | -37110% | --% |
| Nonoperating Income | -- | -- | (0.4) |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (10.2) | (11.0) | (12.2) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (10.2) | (11.0) | (12.2) |
| Total Net Income | (10.2) | (11.0) | (12.2) |
| Net Profit Margin | -3570% | -36600% | --% |
| Diluted EPS from Total Net Income | (4.10) | (4.66) | (5.63) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
NxStage Medical, Inc. Balance Sheet
| Assets | Dec 03 | Dec 02 | Dec 01 |
| Current Assets | |||
| Cash | 8.9 | -- | -- |
| Net Receivables | 0.1 | -- | -- |
| Inventories | 3.2 | -- | -- |
| Other Current Assets | 0.1 | -- | -- |
| Total Current Assets | 12.2 | -- | -- |
| Net Fixed Assets | 0.9 | -- | -- |
| Other Noncurrent Assets | 0.5 | 8.0 | 19.3 |
| Total Assets | 13.6 | 8.0 | 19.3 |
| Liabilities | Dec 03 | Dec 02 | Dec 01 |
| Current Liabilities | |||
| Accounts Payable | 0.3 | -- | -- |
| Short-Term Debt | 0.1 | -- | -- |
| Other Current Liabilities | 0.7 | -- | -- |
| Total Current Liabilities | 1.1 | -- | -- |
| Long-Term Debt | 0.0 | -- | -- |
| Other Noncurrent Liabilities | 55.9 | 41.3 | 41.7 |
| Total Liabilities | 57.1 | 41.3 | 41.7 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | (43.5) | (33.3) | (22.4) |
| Total Equity | (43.5) | (33.3) | (22.4) |
| Shares Outstanding (thou.) | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
NxStage Medical, Inc. Cash Flow Statement
| Dec 03 | Dec 02 | Dec 01 | |
| Net Operating Cash Flow | (11) | -- | -- |
| Net Investing Cash Flow | (0.1) | -- | -- |
| Net Financing Cash Flow | 15.8 | ||
| Net Change in Cash | 4.9 | ||
| Depreciation & Amortization | 0.4 | ||
| Capital Expenditures | (0.1) | ||
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.